期刊文献+

前列腺泡沫状腺癌一例报告

原文传递
导出
摘要 患者,男,64岁。因排尿困难3个月于2018年3月16日入院。尿常规:红细胞计数186个/ul。血清PSA149.22ng/ml,fPSA7.61ng/ml。B超检查:前列腺增生,大小6.1cm×4.8cm×4.8cm。前列腺MRI检查:前列腺体积增大,右侧及左侧叶见片状异常低信号,DWI见病灶高信号改变,T2见病灶略低信号,盆腔内和右侧盆腔间隙见稍肿大淋巴结影;两侧腹股沟见多发小淋巴结影;考虑为前列腺癌。前列腺穿刺活检病理:前列腺腺癌,Gleason评分4+3分。胸部X片、骨扫描未见肿瘤转移。患者在全麻下行腹腔镜根治性前列腺切除术,术后病理检查:低倍镜下瘤细胞类似透明状,由小腺管或腺泡状结构组成,肿瘤在前列腺间质内弥漫浸润性生长。高倍镜下瘤细胞胞质丰富,淡红色,呈泡沫状,酷似黄色瘤细胞,细胞核小,深染,核质比例小,核无明显异形性,核仁不明显。免疫组化染色检查:泡沫状肿瘤细胞表达PSA、PAP和P504S,不表达34βE12、CD68、Lysozyme、S-100、P63。病理诊断:前列腺泡沫状腺癌,Gleason评分4+4分,左髂血管旁淋巴结3/6枚、右髂血管旁淋巴结1/5枚见癌转移,精囊和输精管未受累。临床分期T2cN1M0。术后患者口服比卡鲁胺50mg/d,6个月后行全身骨显像未见明显异常。随访17个月,无复发和转移。
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2019年第10期790-790,共1页 Chinese Journal of Urology
  • 相关文献

参考文献4

二级参考文献57

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61 : 69-90.
  • 2Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients : preoperative application in prostate cancer. Curr Opin Urol, 2003, 13: 111-116.
  • 3Cooperberg RM, Cowan J, Broering M J, et al. High risk prostate cancer in the United States, 1990 -2007. World J Urol, 2008, 26: 211-218.
  • 4Peyromaure M, Debre B, Mao K, et al. Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol, 2005, 174: 1794-1797.
  • 5D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 1998, 280: 969-974.
  • 6Scardino P. Update: NCCN prostate cancer Clinical Practice Guidelines. J Natl Compr Canc Netw, 2005, 3 (Suppl 1) : S29-33.
  • 7Yossepowitch O, Eggener SE, Serio AM, et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol, 2008, 53 : 950-959.
  • 8Spahn M, Joniau S, Gontero P, et al. Outcome predictors of radical prostateetomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients. Eur Urol, 2010, 58: 1-7.
  • 9Stephenson A J, Kattan MW, Eastham JA, et al. Prostate cancerspecific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol, 2009, 27 : 4300- 4305.
  • 10Lughezzani G, Gallina A, Larcher A, et al. Radical prostatectomy represents an effective treatment in patients with specimen- confined high pathological Gleason score prostate cancer [J/ OL]. BJU Int, 2012 [2012-05-07]. http://onlinelibrary, wiley. com/doi/10.1111/j. 1464-410X. 2012. 11114. x/full[published online ahead of print April 4, 2012].

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部